Related Experiment Videos
Chloral hydrate toxicity in a preterm infant
Insights
Ventilator use in premature infants with hyaline membrane disease can be challenging. A case report details severe chloral hydrate toxicity in a preterm infant, highlighting risks associated with this sedative for managing respiratory distress.
Area of Science:
- Neonatal Medicine
- Pediatric Critical Care
- Pharmacology
Background:
- Hyaline membrane disease (HMD) in premature infants often requires mechanical ventilation.
- Infants may exhibit irritability and resist ventilation, leading to hypoxemia.
- Neuromuscular blockade is a common but limiting strategy for managing ventilator dyssynchrony.
Observation:
- Chloral hydrate, a sedative-hypnotic, has been used adjunctively to improve ventilation in HMD.
- This approach can mask important clinical signs of infant status.
- A case of severe chloral hydrate toxicity was observed in a preterm infant.
Findings:
- The case highlights a significant adverse event associated with chloral hydrate use in neonates.
- Toxicity occurred despite its intended use as an adjunct to ventilator therapy.
- This underscores the potential risks of sedative use in critically ill preterm infants.
Implications:
- Clinicians should exercise caution when using chloral hydrate in premature infants with HMD.
- Alternative strategies for managing ventilator dyssynchrony may be needed.
- Further research into safer sedation or non-pharmacological methods is warranted.
Abstract:
Ventilator care in premature infants with hyaline membrane disease (HMD) may be complicated by episodes of irritability and "fighting" the respirator, resulting in significant hypoxemia. Neuromuscular blockade with pharmacologic agents such as pancuronium bromide is frequently used to manage this problem [Crone and Favorito, 1980]. This therapy results in the loss of important clinical signs, such as alterations in muscle tone and spontaneous movements, which are important in monitoring the critically ill newborn. As a result of these considerations, we occasionally have utilized the sedative-hypnotic effects of chloral hydrate to achieve adequate ventilation and oxygenation in these infants. We report, however, a case of a preterm infant who developed severe chloral hydrate toxicity after its administration as an adjunct to the treatment of HMD.